JP2024528534A5 - - Google Patents
Info
- Publication number
- JP2024528534A5 JP2024528534A5 JP2023580680A JP2023580680A JP2024528534A5 JP 2024528534 A5 JP2024528534 A5 JP 2024528534A5 JP 2023580680 A JP2023580680 A JP 2023580680A JP 2023580680 A JP2023580680 A JP 2023580680A JP 2024528534 A5 JP2024528534 A5 JP 2024528534A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- ltbr
- acid sequence
- modified
- sequence encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163217014P | 2021-06-30 | 2021-06-30 | |
| US63/217,014 | 2021-06-30 | ||
| US202163287389P | 2021-12-08 | 2021-12-08 | |
| US63/287,389 | 2021-12-08 | ||
| US202263320101P | 2022-03-15 | 2022-03-15 | |
| US63/320,101 | 2022-03-15 | ||
| PCT/US2022/073294 WO2023279049A1 (en) | 2021-06-30 | 2022-06-30 | Methods and compositions for improved immunotherapies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528534A JP2024528534A (ja) | 2024-07-30 |
| JP2024528534A5 true JP2024528534A5 (https=) | 2025-07-04 |
Family
ID=84693004
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023580680A Pending JP2024528534A (ja) | 2021-06-30 | 2022-06-30 | 改善した免疫療法のための方法及び組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240307444A1 (https=) |
| EP (1) | EP4362958A4 (https=) |
| JP (1) | JP2024528534A (https=) |
| KR (1) | KR20240090127A (https=) |
| AU (1) | AU2022305356A1 (https=) |
| CA (1) | CA3223720A1 (https=) |
| IL (1) | IL309734A (https=) |
| MX (1) | MX2024000112A (https=) |
| WO (1) | WO2023279049A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2025014741A (es) * | 2023-06-06 | 2026-02-03 | Astrazeneca Ab | Celulas t blindadas |
| WO2025184170A1 (en) * | 2024-02-27 | 2025-09-04 | Overt Bio, Inc. | Methods and compositions for improving t cell function in an immunosuppressive environment |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11866731B2 (en) * | 2017-11-10 | 2024-01-09 | Chineo Medical Technology Co., Ltd | Modified immune cells and uses thereof |
| EP3710471A1 (en) * | 2017-11-16 | 2020-09-23 | Kite Pharma, Inc. | Modified chimeric antigen receptors and methods of use |
| AU2019317229A1 (en) * | 2018-08-10 | 2021-02-18 | Eutilex Co.,Ltd | Chimeric Antigen Receptor that Binds HLA-DR, and CAR-T Cell |
| AU2019397033B2 (en) * | 2018-12-12 | 2023-06-29 | Kite Pharma, Inc. | Chimeric antigen receptors and CAR-T cells and methods of use |
| EP4251645A1 (en) * | 2020-11-25 | 2023-10-04 | Catamaran Bio, Inc. | Cellular therapeutics engineered with signal modulators and methods of use thereof |
-
2022
- 2022-06-30 EP EP22834421.4A patent/EP4362958A4/en active Pending
- 2022-06-30 CA CA3223720A patent/CA3223720A1/en active Pending
- 2022-06-30 AU AU2022305356A patent/AU2022305356A1/en active Pending
- 2022-06-30 MX MX2024000112A patent/MX2024000112A/es unknown
- 2022-06-30 KR KR1020247003549A patent/KR20240090127A/ko active Pending
- 2022-06-30 WO PCT/US2022/073294 patent/WO2023279049A1/en not_active Ceased
- 2022-06-30 JP JP2023580680A patent/JP2024528534A/ja active Pending
- 2022-06-30 US US18/576,076 patent/US20240307444A1/en active Pending
- 2022-06-30 IL IL309734A patent/IL309734A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dynlacht et al. | Functional analysis of NTF-1, a developmentally regulated Drosophila transcription factor that binds neuronal cis elements. | |
| Penninger et al. | The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes | |
| Hagman et al. | A novel lineage‐specific nuclear factor regulates mb‐1 gene transcription at the early stages of B cell differentiation. | |
| Usui et al. | GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12Rβ2 chain or T-bet | |
| JP4829272B2 (ja) | Ｅｓ細胞特異的発現遺伝子 | |
| JP2021518160A5 (https=) | ||
| JP2021518161A5 (https=) | ||
| US20030054362A1 (en) | In vitro cell-based methods for biological validation and pharmacological screening of chemical entities and biologicals | |
| AU2018329741A2 (en) | Compositions and methods for chimeric ligand receptor (CLR)-mediated conditional gene expression | |
| JP2024528534A5 (https=) | ||
| Mizuki et al. | RFLP analysis in the TNF-beta gene and the susceptibility to alloreactive NK cells in Behçet's disease. | |
| Chestkov et al. | The d4 gene family in the human genome | |
| JP2007502129A (ja) | 短鎖干渉ｒｎａライブラリーならびに合成および使用の方法 | |
| JP2024519513A (ja) | 細胞トランスクリプトームのコンビナトリアル標的化のための方法及び組成物 | |
| EP3529352A2 (en) | Natural killer t (nkt) cells comprising engineered t cell receptors | |
| Gainer et al. | Vasopressin gene expression: experimental models and strategies | |
| Lim et al. | Isolation of murine and human homologues of the fission-yeast dis3+ gene encoding a mitotic-control protein and its overexpression in cancer cells with progressive phenotype | |
| JP2007504840A5 (https=) | ||
| KR101822731B1 (ko) | 파골세포 분화를 촉진하는 ｍｍｐ－９의 용도 | |
| JP2020528046A (ja) | Ｔ細胞に基づく免疫療法の有効性増強のための組成物および方法 | |
| KR20060116825A (ko) | 바이러스 감염에 대한 저항성과 관련된 유전자인ｏａｓ1에서의 돌연변이의 검출 | |
| CN104711240B (zh) | 禽呼肠孤病毒σA蛋白及其相关生物材料的应用 | |
| CN103957695A (zh) | 编码在黄麻中赋予疾病抗性的酶的核酸分子 | |
| US20090081682A1 (en) | High-throughput methods for identifying gene function using lentiviral vectors | |
| Livesey et al. | Differential display cloning of genes induced in regenerating neurons |